We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$274B
AUM Growth
+$5.82B
Cap. Flow
-$10.4B
Cap. Flow %
-3.8%
Top 10 Hldgs %
16.33%
Holding
11,664
New
983
Increased
3,962
Reduced
4,260
Closed
2,127

Sector Composition

Rank Sector Weight
1 Technology 12.29%
2 Financials 8.09%
3 Healthcare 6.75%
4 Consumer Discretionary 5.04%
5 Industrials 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPDV icon
8226
AAM S&P 500 High Dividend Value ETF
SPDV
$104M
$3.64K ﹤0.01%
129
-1,581
-92% -$46.2K
OXBR icon
8227
Oxbridge Re Holdings
OXBR
$10.8M
$3.62K ﹤0.01%
2,071
-3,747
-64% -$7.66K
GCMGW
8228
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$3.61K ﹤0.01%
6,400
+1,269
+25% +$970
IAF
8229
abrdn Australia Equity Fund
IAF
$127M
$3.61K ﹤0.01%
274
-781
-74% -$11K
BLTE
8230
Belite Bio
BLTE
$6.54B
$3.59K ﹤0.01%
120
-4,097
-97% -$125K
IPHA
8231
Innate Pharma
IPHA
$162M
$3.59K ﹤0.01%
1,259
+1,113
+762% +$3.58K
DXF
8232
Eason Technology Ltd
DXF
$1.55M
$3.58K ﹤0.01%
20
-28
-58% -$6.11K
LUCD icon
8233
Lucid Diagnostics
LUCD
$184M
$3.58K ﹤0.01%
2,558
-1,007
-28% -$1.39K
RLMD icon
8234
Relmada Therapeutics
RLMD
$519M
$3.57K ﹤0.01%
1,578
-4,335
-73% -$14.9K
ORKA
8235
Oruka Therapeutics
ORKA
$5.96B
$3.56K ﹤0.01%
149
+24
+19% +$632
KRMD icon
8236
KORU Medical Systems
KRMD
$164M
$3.55K ﹤0.01%
+842
New +$3.31K
RC.PRC
8237
Ready Capital Corp 6.25% Series C Preferred Stock
RC.PRC
$4.27M
$3.55K ﹤0.01%
+200
New +$3.74K
MTEX icon
8238
Mannatech
MTEX
$9.24M
$3.54K ﹤0.01%
205
-1,151
-85% -$19.6K
SQEW
8239
DELISTED
LeaderShares Equity Skew ETF
SQEW
$3.54K ﹤0.01%
122
+79
+184% +$2.29K
ORN icon
8240
Orion Group Holdings
ORN
$418M
$3.54K ﹤0.01%
1,365
-3,635
-73% -$10.1K
ACOR
8241
DELISTED
Acorda Therapeutics
ACOR
$3.53K ﹤0.01%
301
-364
-55% -$6.05K
SPXT icon
8242
ProShares S&P 500 ex-Technology ETF
SPXT
$288M
$3.52K ﹤0.01%
51
-515
-91% -$35.6K
JJS
8243
DELISTED
iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN
JJS
$3.52K ﹤0.01%
54
+25
+86% +$1.56K
GFOF
8244
DELISTED
Grayscale Future of Finance ETF
GFOF
$3.52K ﹤0.01%
329
-3,502
-91% -$36.6K
FSEC icon
8245
Fidelity Investment Grade Securitized ETF
FSEC
$4.64B
$3.52K ﹤0.01%
82
+74
+925% +$3.18K
INKT icon
8246
MiNK Therapeutics
INKT
$54.6M
$3.51K ﹤0.01%
185
-65
-26% -$1.41K
AGIL
8247
DELISTED
AgileThought Inc
AGIL
$3.51K ﹤0.01%
1,113
-2,832
-72% -$11.6K
INVZ icon
8248
Innoviz Technologies
INVZ
$112M
$3.5K ﹤0.01%
1,000
NB
8249
NioCorp Developments
NB
$780M
$3.5K ﹤0.01%
+550
New +$3.74K
SKYA
8250
SkyAI Inc
SKYA
$51.2M
0

Similar funds

UBS Group's Q1 2023 Portfolio in Review

As of Q1 2023, UBS Group held 11,664 positions worth $274B, up 2.2% from $268B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group withdrew a net $10.4B in Q1 2023, closing 2,127 positions and reducing 4,260 holdings. Its most notable exit was LHC Group LLC, an estimated $49M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in First Trust Nasdaq Oil & Gas ETF worth $13.3M.

  • UBS Group's largest Q1 2023 buy was First Trust Nasdaq Oil & Gas ETF: 493,205 shares worth $13.3M.
  • UBS Group added most to UBS Group in Q1 2023, an estimated $3.78B increase.
  • UBS Group's biggest Q1 2023 reduction was Microsoft, cutting an estimated $820M.
  • UBS Group fully exited LHC Group LLC in Q1 2023, selling an estimated $49M.
  • UBS Group's ten largest holdings make up 16% of its $274B portfolio in Q1 2023.
  • UBS Group opened 983 new positions and closed 2,127 in Q1 2023.
  • UBS Group's portfolio value rose 2.2% quarter-over-quarter to $274B.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.